This document outlines 8 learning objectives covering the assessment, diagnosis, neurobiology, and treatment of unipolar and bipolar mood disorders. The objectives address signs and symptoms of depression, the difference between mood and affect, risk factors for suicide, the neurochemistry of serotonin, norepinephrine and dopamine, how stress affects depression through the HPA axis, neurotransmitters involved in bipolar disorder, mechanisms and side effects of antidepressants and mood stabilizers, and psychological therapies for depression.
This document outlines 8 learning objectives covering the assessment, diagnosis, neurobiology, and treatment of unipolar and bipolar mood disorders. The objectives address signs and symptoms of depression, the difference between mood and affect, risk factors for suicide, the neurochemistry of serotonin, norepinephrine and dopamine, how stress affects depression through the HPA axis, neurotransmitters involved in bipolar disorder, mechanisms and side effects of antidepressants and mood stabilizers, and psychological therapies for depression.
This document outlines 8 learning objectives covering the assessment, diagnosis, neurobiology, and treatment of unipolar and bipolar mood disorders. The objectives address signs and symptoms of depression, the difference between mood and affect, risk factors for suicide, the neurochemistry of serotonin, norepinephrine and dopamine, how stress affects depression through the HPA axis, neurotransmitters involved in bipolar disorder, mechanisms and side effects of antidepressants and mood stabilizers, and psychological therapies for depression.
ILO one: How are the various psychopathological signs and symptoms mentioned in the history and mental state examination of the case? What is meant by mood and what is meant by affect? Difference between unipolar, bipolar I, bipolar II? ILO two: Describe the predisposing, triggering and sustaining factors for unipolar mood disorders. Describe the differential diagnosis in unipolar mood disorders (co-occurrence with somatic disorder; co-occurrence with use of/withdrawal from psychoactive agents; anxiety disorders; dementia; schizophrenia; bipolar mood disorders; personality disorders; grief response, burnout). ILO three: SUICIDE: What is meant by suicidal behavior? Name the major risk factors for suicide. Describe the legal method / possibility for a compulsory admission in KSA. ILO Four: Neurobiology Of Unipolar And Bipolar Mood Disorders Pharmacology of serotonin, noradrenaline, Dopamine (precursors, synthesis, breakdown, receptors). Describe the relationship between a disrupted HPA axis and the development of depression. ILO Five: Neurobiology Of Unipolar And Bipolar Mood Disorders Describe neurotransmitters and the brain structures/neurocircuits possibly involved in bipolar disorder. ILO Six: Treatment Of Unipolar Mood Disorders – Pharmacological Knowledge about antidepressants (SSRI, TCA, MAO) mechanism of action. Contraindications and side effects? ILO Seven: Treatment Of Unipolar Mood Disorders – Psychological Describe the non-pharmacological treatment options for depression (e.g. IPT vs. CBT) ILO Eight: Treatment Of Bipolar Disorders – Pharmacological Discuss the various mood stabilizers briefly in terms of indications and mechanism of actions and side effects.